Sample	Replicate	Exp.nbl	Depth	Data	Subsampling	N.nbl.reads	Type	Input.material	Fraction.tp.perc	Fraction.tp	Fraction.ddPCR
5M_mix_Bmap_CLBGA_0_rep1	1	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep1	1	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep1	1	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep1	1	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep1	1	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep1	1	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep1	1	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep1	1	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep1	1	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep1	1	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep1	1	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep1	1	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep1	1	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep1	1	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep1	1	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep2	2	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep2	2	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep2	2	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep2	2	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep2	2	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep2	2	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep2	2	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep2	2	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep2	2	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep2	2	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep2	2	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep2	2	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep2	2	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep2	2	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep2	2	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep3	3	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep3	3	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep3	3	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep3	3	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep3	3	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep3	3	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep3	3	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep3	3	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep3	3	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep3	3	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep3	3	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep3	3	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep3	3	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep3	3	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep3	3	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep4	4	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep4	4	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep4	4	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep4	4	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep4	4	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep4	4	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep4	4	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep4	4	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep4	4	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep4	4	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep4	4	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep4	4	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep4	4	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep4	4	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep4	4	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep5	5	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep5	5	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep5	5	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep5	5	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep5	5	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep5	5	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep5	5	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep5	5	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep5	5	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep5	5	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep5	5	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep5	5	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep5	5	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep5	5	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep5	5	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep6	6	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep6	6	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep6	6	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep6	6	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep6	6	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep6	6	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep6	6	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep6	6	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep6	6	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep6	6	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep6	6	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep6	6	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep6	6	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep6	6	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep6	6	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep7	7	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep7	7	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep7	7	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep7	7	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep7	7	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep7	7	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep7	7	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep7	7	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep7	7	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep7	7	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep7	7	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep7	7	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep7	7	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep7	7	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep7	7	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep8	8	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep8	8	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep8	8	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep8	8	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep8	8	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep8	8	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep8	8	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep8	8	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep8	8	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep8	8	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep8	8	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep8	8	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep8	8	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep8	8	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep8	8	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep9	9	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep9	9	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep9	9	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep9	9	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep9	9	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep9	9	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep9	9	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep9	9	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep9	9	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep9	9	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep9	9	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep9	9	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep9	9	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep9	9	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep9	9	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep10	10	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep10	10	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep10	10	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep10	10	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep10	10	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep10	10	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep10	10	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep10	10	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep10	10	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep10	10	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep10	10	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep10	10	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep10	10	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep10	10	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep10	10	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep11	11	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep11	11	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep11	11	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep11	11	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep11	11	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep11	11	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep11	11	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep11	11	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep11	11	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep11	11	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep11	11	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep11	11	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep11	11	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep11	11	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep11	11	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep12	12	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep12	12	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep12	12	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep12	12	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep12	12	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep12	12	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep12	12	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep12	12	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep12	12	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep12	12	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep12	12	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep12	12	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep12	12	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep12	12	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep12	12	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep13	13	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep13	13	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep13	13	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep13	13	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep13	13	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep13	13	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep13	13	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep13	13	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep13	13	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep13	13	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep13	13	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep13	13	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep13	13	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep13	13	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep13	13	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep14	14	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep14	14	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep14	14	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep14	14	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep14	14	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep14	14	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep14	14	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep14	14	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep14	14	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep14	14	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep14	14	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep14	14	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep14	14	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep14	14	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep14	14	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep15	15	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep15	15	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep15	15	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep15	15	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep15	15	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep15	15	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep15	15	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep15	15	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep15	15	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep15	15	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep15	15	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep15	15	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep15	15	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep15	15	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep15	15	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep16	16	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep16	16	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep16	16	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep16	16	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep16	16	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep16	16	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep16	16	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep16	16	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep16	16	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep16	16	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep16	16	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep16	16	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep16	16	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep16	16	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep16	16	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000	in Silico	NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep17	17	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep17	17	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep17	17	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep17	17	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep17	17	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep17	17	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep17	17	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep17	17	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep17	17	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep17	17	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep17	17	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep17	17	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep17	17	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep17	17	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep17	17	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep18	18	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep18	18	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep18	18	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep18	18	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep18	18	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep18	18	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep18	18	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep18	18	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep18	18	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep18	18	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep18	18	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep18	18	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep18	18	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep18	18	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep18	18	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep19	19	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep19	19	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep19	19	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep19	19	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep19	19	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep19	19	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep19	19	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep19	19	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep19	19	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep19	19	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep19	19	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep19	19	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep19	19	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep19	19	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep19	19	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep20	20	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep20	20	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep20	20	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep20	20	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep20	20	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep20	20	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep20	20	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep20	20	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep20	20	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep20	20	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep20	20	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep20	20	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep20	20	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep20	20	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep20	20	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep21	21	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep21	21	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep21	21	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep21	21	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep21	21	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep21	21	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep21	21	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep21	21	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep21	21	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep21	21	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep21	21	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep21	21	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep21	21	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep21	21	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep21	21	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep22	22	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep22	22	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep22	22	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep22	22	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep22	22	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep22	22	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep22	22	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep22	22	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep22	22	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep22	22	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep22	22	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep22	22	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep22	22	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep22	22	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep22	22	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep23	23	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep23	23	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep23	23	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep23	23	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep23	23	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep23	23	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep23	23	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep23	23	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep23	23	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep23	23	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep23	23	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep23	23	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep23	23	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep23	23	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep23	23	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep24	24	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep24	24	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep24	24	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep24	24	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep24	24	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep24	24	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep24	24	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep24	24	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep24	24	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep24	24	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep24	24	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep24	24	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep24	24	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep24	24	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep24	24	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep25	25	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep25	25	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep25	25	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep25	25	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep25	25	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep25	25	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep25	25	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep25	25	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep25	25	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep25	25	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep25	25	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep25	25	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep25	25	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep25	25	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep25	25	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep26	26	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep26	26	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep26	26	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep26	26	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep26	26	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep26	26	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep26	26	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep26	26	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep26	26	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep26	26	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep26	26	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep26	26	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep26	26	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep26	26	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep26	26	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep27	27	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep27	27	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep27	27	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep27	27	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep27	27	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep27	27	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep27	27	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep27	27	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep27	27	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep27	27	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep27	27	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep27	27	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep27	27	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep27	27	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep27	27	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep28	28	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep28	28	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep28	28	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep28	28	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep28	28	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep28	28	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep28	28	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep28	28	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep28	28	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep28	28	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep28	28	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep28	28	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep28	28	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep28	28	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep28	28	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep29	29	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep29	29	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep29	29	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep29	29	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep29	29	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep29	29	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep29	29	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep29	29	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep29	29	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep29	29	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep29	29	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep29	29	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep29	29	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep29	29	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep29	29	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep30	30	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep30	30	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep30	30	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep30	30	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep30	30	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep30	30	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep30	30	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep30	30	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep30	30	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep30	30	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep30	30	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep30	30	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep30	30	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep30	30	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep30	30	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep31	31	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep31	31	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep31	31	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep31	31	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep31	31	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep31	31	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep31	31	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep31	31	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep31	31	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep31	31	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep31	31	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep31	31	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep31	31	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep31	31	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep31	31	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep32	32	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep32	32	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep32	32	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep32	32	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep32	32	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep32	32	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep32	32	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep32	32	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep32	32	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep32	32	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep32	32	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep32	32	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep32	32	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep32	32	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep32	32	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep33	33	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep33	33	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep33	33	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep33	33	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep33	33	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep33	33	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep33	33	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep33	33	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep33	33	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep33	33	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep33	33	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep33	33	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep33	33	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep33	33	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep33	33	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep34	34	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep34	34	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep34	34	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep34	34	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep34	34	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep34	34	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep34	34	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep34	34	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep34	34	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep34	34	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep34	34	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep34	34	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep34	34	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep34	34	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep34	34	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep35	35	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep35	35	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep35	35	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep35	35	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep35	35	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep35	35	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep35	35	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep35	35	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep35	35	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep35	35	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep35	35	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep35	35	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep35	35	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep35	35	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep35	35	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep36	36	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep36	36	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep36	36	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep36	36	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep36	36	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep36	36	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep36	36	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep36	36	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep36	36	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep36	36	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep36	36	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep36	36	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep36	36	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep36	36	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep36	36	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep37	37	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep37	37	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep37	37	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep37	37	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep37	37	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep37	37	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep37	37	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep37	37	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep37	37	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep37	37	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep37	37	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep37	37	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep37	37	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep37	37	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep37	37	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep38	38	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep38	38	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep38	38	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep38	38	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep38	38	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep38	38	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep38	38	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep38	38	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep38	38	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep38	38	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep38	38	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep38	38	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep38	38	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep38	38	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep38	38	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep39	39	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep39	39	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep39	39	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep39	39	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep39	39	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep39	39	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep39	39	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep39	39	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep39	39	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep39	39	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep39	39	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep39	39	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep39	39	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep39	39	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep39	39	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep40	40	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep40	40	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep40	40	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep40	40	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep40	40	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep40	40	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep40	40	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep40	40	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep40	40	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep40	40	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep40	40	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep40	40	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep40	40	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep40	40	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep40	40	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep41	41	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep41	41	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep41	41	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep41	41	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep41	41	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep41	41	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep41	41	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep41	41	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep41	41	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep41	41	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep41	41	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep41	41	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep41	41	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep41	41	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep41	41	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep42	42	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep42	42	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep42	42	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep42	42	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep42	42	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep42	42	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep42	42	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep42	42	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep42	42	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep42	42	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep42	42	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep42	42	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep42	42	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep42	42	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep42	42	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep43	43	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep43	43	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep43	43	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep43	43	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep43	43	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep43	43	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep43	43	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep43	43	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep43	43	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep43	43	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep43	43	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep43	43	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep43	43	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep43	43	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep43	43	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep44	44	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep44	44	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep44	44	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep44	44	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep44	44	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep44	44	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep44	44	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep44	44	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep44	44	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep44	44	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep44	44	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep44	44	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep44	44	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep44	44	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep44	44	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep45	45	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep45	45	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep45	45	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep45	45	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep45	45	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep45	45	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep45	45	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep45	45	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep45	45	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep45	45	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep45	45	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep45	45	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep45	45	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep45	45	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep45	45	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep46	46	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep46	46	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep46	46	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep46	46	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep46	46	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep46	46	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep46	46	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep46	46	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep46	46	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep46	46	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep46	46	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep46	46	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep46	46	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep46	46	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep46	46	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep47	47	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep47	47	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep47	47	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep47	47	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep47	47	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep47	47	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep47	47	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep47	47	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep47	47	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep47	47	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep47	47	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep47	47	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep47	47	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep47	47	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep47	47	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep48	48	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep48	48	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep48	48	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep48	48	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep48	48	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep48	48	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep48	48	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep48	48	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep48	48	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep48	48	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep48	48	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep48	48	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep48	48	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep48	48	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep48	48	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep49	49	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep49	49	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep49	49	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep49	49	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep49	49	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep49	49	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep49	49	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep49	49	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep49	49	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep49	49	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep49	49	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep49	49	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep49	49	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep49	49	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep49	49	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep50	50	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep50	50	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep50	50	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep50	50	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep50	50	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep50	50	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep50	50	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep50	50	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep50	50	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep50	50	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep50	50	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep50	50	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep50	50	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep50	50	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep50	50	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep51	51	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep51	51	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep51	51	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep51	51	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep51	51	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep51	51	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep51	51	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep51	51	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep51	51	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep51	51	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep51	51	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep51	51	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep51	51	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep51	51	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep51	51	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep52	52	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep52	52	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep52	52	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep52	52	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep52	52	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep52	52	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep52	52	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep52	52	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep52	52	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep52	52	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep52	52	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep52	52	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep52	52	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep52	52	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep52	52	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep53	53	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep53	53	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep53	53	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep53	53	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep53	53	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep53	53	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep53	53	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep53	53	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep53	53	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep53	53	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep53	53	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep53	53	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep53	53	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep53	53	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep53	53	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep54	54	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep54	54	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep54	54	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep54	54	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep54	54	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep54	54	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep54	54	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep54	54	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep54	54	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep54	54	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep54	54	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep54	54	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep54	54	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep54	54	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep54	54	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep55	55	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep55	55	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep55	55	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep55	55	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep55	55	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep55	55	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep55	55	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep55	55	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep55	55	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep55	55	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep55	55	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep55	55	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep55	55	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep55	55	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep55	55	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep56	56	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep56	56	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep56	56	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep56	56	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep56	56	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep56	56	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep56	56	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep56	56	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep56	56	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep56	56	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep56	56	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep56	56	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep56	56	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep56	56	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep56	56	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep57	57	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep57	57	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep57	57	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep57	57	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep57	57	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep57	57	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep57	57	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep57	57	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep57	57	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep57	57	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep57	57	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep57	57	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep57	57	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep57	57	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep57	57	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep58	58	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep58	58	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep58	58	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep58	58	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep58	58	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep58	58	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep58	58	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep58	58	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep58	58	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep58	58	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep58	58	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep58	58	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep58	58	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep58	58	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep58	58	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep59	59	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep59	59	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep59	59	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep59	59	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep59	59	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep59	59	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep59	59	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep59	59	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep59	59	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep59	59	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep59	59	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep59	59	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep59	59	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep59	59	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep59	59	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0_rep60	60	0	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-01_rep60	60	1e-04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-1_rep60	60	0.001	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-11_rep60	60	0.0011	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5500		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-3_rep60	60	0.003	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_0-7_rep60	60	0.007	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	35000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1_rep60	60	0.01	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	50000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_1-8_rep60	60	0.018	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	90000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_2-5_rep60	60	0.025	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	125000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_4_rep60	60	0.04	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_5_rep60	60	0.05	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_10_rep60	60	0.1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_25_rep60	60	0.25	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1250000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_50_rep60	60	0.5	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
5M_mix_Bmap_CLBGA_100_rep60	60	1	5000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep1	1	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep1	1	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep1	1	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep1	1	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep1	1	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep1	1	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep1	1	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep1	1	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep1	1	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep1	1	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep1	1	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep1	1	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep1	1	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep1	1	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep1	1	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep2	2	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep2	2	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep2	2	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep2	2	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep2	2	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep2	2	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep2	2	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep2	2	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep2	2	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep2	2	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep2	2	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep2	2	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep2	2	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep2	2	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep2	2	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep3	3	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep3	3	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep3	3	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep3	3	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep3	3	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep3	3	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep3	3	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep3	3	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep3	3	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep3	3	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep3	3	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep3	3	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep3	3	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep3	3	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep3	3	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep4	4	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep4	4	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep4	4	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep4	4	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep4	4	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep4	4	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep4	4	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep4	4	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep4	4	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep4	4	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep4	4	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep4	4	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep4	4	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep4	4	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep4	4	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep5	5	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep5	5	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep5	5	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep5	5	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep5	5	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep5	5	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep5	5	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep5	5	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep5	5	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep5	5	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep5	5	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep5	5	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep5	5	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep5	5	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep5	5	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep6	6	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep6	6	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep6	6	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep6	6	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep6	6	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep6	6	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep6	6	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep6	6	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep6	6	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep6	6	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep6	6	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep6	6	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep6	6	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep6	6	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep6	6	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep7	7	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep7	7	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep7	7	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep7	7	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep7	7	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep7	7	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep7	7	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep7	7	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep7	7	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep7	7	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep7	7	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep7	7	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep7	7	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep7	7	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep7	7	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep8	8	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep8	8	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep8	8	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep8	8	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep8	8	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep8	8	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep8	8	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep8	8	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep8	8	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep8	8	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep8	8	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep8	8	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep8	8	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep8	8	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep8	8	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep9	9	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep9	9	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep9	9	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep9	9	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep9	9	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep9	9	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep9	9	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep9	9	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep9	9	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep9	9	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep9	9	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep9	9	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep9	9	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep9	9	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep9	9	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep10	10	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep10	10	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep10	10	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep10	10	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep10	10	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep10	10	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep10	10	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep10	10	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep10	10	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep10	10	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep10	10	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep10	10	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep10	10	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep10	10	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep10	10	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep11	11	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep11	11	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep11	11	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep11	11	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep11	11	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep11	11	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep11	11	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep11	11	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep11	11	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep11	11	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep11	11	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep11	11	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep11	11	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep11	11	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep11	11	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep12	12	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep12	12	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep12	12	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep12	12	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep12	12	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep12	12	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep12	12	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep12	12	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep12	12	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep12	12	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep12	12	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep12	12	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep12	12	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep12	12	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep12	12	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep13	13	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep13	13	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep13	13	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep13	13	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep13	13	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep13	13	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep13	13	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep13	13	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep13	13	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep13	13	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep13	13	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep13	13	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep13	13	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep13	13	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep13	13	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep14	14	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep14	14	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep14	14	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep14	14	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep14	14	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep14	14	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep14	14	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep14	14	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep14	14	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep14	14	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep14	14	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep14	14	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep14	14	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep14	14	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep14	14	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep15	15	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep15	15	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep15	15	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep15	15	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep15	15	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep15	15	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep15	15	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep15	15	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep15	15	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep15	15	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep15	15	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep15	15	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep15	15	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep15	15	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep15	15	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep16	16	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep16	16	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep16	16	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep16	16	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep16	16	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep16	16	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep16	16	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep16	16	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep16	16	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep16	16	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep16	16	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep16	16	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep16	16	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep16	16	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep16	16	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep17	17	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep17	17	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep17	17	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep17	17	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep17	17	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep17	17	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep17	17	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep17	17	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep17	17	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep17	17	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep17	17	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep17	17	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep17	17	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep17	17	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep17	17	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep18	18	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep18	18	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep18	18	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep18	18	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep18	18	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep18	18	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep18	18	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep18	18	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep18	18	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep18	18	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep18	18	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep18	18	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep18	18	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep18	18	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep18	18	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep19	19	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep19	19	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep19	19	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep19	19	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep19	19	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep19	19	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep19	19	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep19	19	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep19	19	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep19	19	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep19	19	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep19	19	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep19	19	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep19	19	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep19	19	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep20	20	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep20	20	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep20	20	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep20	20	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep20	20	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep20	20	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep20	20	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep20	20	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep20	20	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep20	20	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep20	20	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep20	20	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep20	20	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep20	20	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep20	20	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep21	21	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep21	21	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep21	21	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep21	21	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep21	21	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep21	21	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep21	21	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep21	21	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep21	21	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep21	21	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep21	21	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep21	21	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep21	21	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep21	21	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep21	21	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep22	22	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep22	22	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep22	22	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep22	22	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep22	22	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep22	22	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep22	22	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep22	22	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep22	22	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep22	22	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep22	22	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep22	22	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep22	22	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep22	22	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep22	22	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep23	23	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep23	23	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep23	23	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep23	23	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep23	23	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep23	23	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep23	23	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep23	23	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep23	23	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep23	23	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep23	23	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep23	23	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep23	23	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep23	23	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep23	23	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep24	24	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep24	24	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep24	24	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep24	24	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep24	24	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep24	24	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep24	24	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep24	24	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep24	24	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep24	24	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep24	24	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep24	24	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep24	24	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep24	24	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep24	24	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep25	25	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep25	25	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep25	25	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep25	25	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep25	25	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep25	25	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep25	25	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep25	25	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep25	25	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep25	25	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep25	25	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep25	25	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep25	25	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep25	25	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep25	25	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep26	26	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep26	26	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep26	26	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep26	26	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep26	26	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep26	26	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep26	26	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep26	26	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep26	26	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep26	26	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep26	26	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep26	26	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep26	26	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep26	26	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep26	26	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep27	27	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep27	27	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep27	27	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep27	27	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep27	27	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep27	27	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep27	27	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep27	27	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep27	27	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep27	27	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep27	27	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep27	27	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep27	27	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep27	27	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep27	27	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep28	28	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep28	28	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep28	28	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep28	28	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep28	28	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep28	28	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep28	28	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep28	28	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep28	28	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep28	28	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep28	28	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep28	28	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep28	28	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep28	28	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep28	28	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep29	29	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep29	29	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep29	29	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep29	29	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep29	29	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep29	29	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep29	29	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep29	29	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep29	29	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep29	29	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep29	29	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep29	29	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep29	29	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep29	29	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep29	29	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep30	30	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep30	30	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep30	30	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep30	30	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep30	30	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep30	30	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep30	30	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep30	30	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep30	30	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep30	30	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep30	30	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep30	30	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep30	30	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep30	30	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep30	30	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep31	31	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep31	31	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep31	31	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep31	31	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep31	31	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep31	31	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep31	31	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep31	31	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep31	31	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep31	31	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep31	31	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep31	31	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep31	31	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep31	31	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep31	31	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep32	32	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep32	32	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep32	32	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep32	32	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep32	32	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep32	32	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep32	32	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep32	32	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep32	32	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep32	32	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep32	32	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep32	32	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep32	32	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep32	32	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep32	32	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep33	33	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep33	33	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep33	33	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep33	33	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep33	33	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep33	33	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep33	33	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep33	33	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep33	33	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep33	33	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep33	33	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep33	33	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep33	33	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep33	33	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep33	33	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep34	34	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep34	34	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep34	34	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep34	34	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep34	34	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep34	34	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep34	34	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep34	34	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep34	34	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep34	34	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep34	34	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep34	34	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep34	34	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep34	34	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep34	34	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep35	35	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep35	35	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep35	35	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep35	35	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep35	35	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep35	35	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep35	35	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep35	35	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep35	35	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep35	35	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep35	35	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep35	35	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep35	35	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep35	35	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep35	35	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep36	36	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep36	36	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep36	36	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep36	36	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep36	36	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep36	36	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep36	36	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep36	36	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep36	36	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep36	36	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep36	36	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep36	36	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep36	36	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep36	36	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep36	36	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep37	37	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep37	37	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep37	37	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep37	37	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep37	37	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep37	37	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep37	37	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep37	37	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep37	37	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep37	37	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep37	37	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep37	37	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep37	37	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep37	37	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep37	37	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep38	38	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep38	38	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep38	38	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep38	38	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep38	38	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep38	38	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep38	38	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep38	38	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep38	38	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep38	38	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep38	38	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep38	38	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep38	38	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep38	38	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep38	38	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep39	39	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep39	39	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep39	39	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep39	39	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep39	39	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep39	39	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep39	39	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep39	39	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep39	39	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep39	39	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep39	39	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep39	39	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep39	39	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep39	39	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep39	39	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep40	40	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep40	40	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep40	40	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep40	40	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep40	40	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep40	40	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep40	40	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep40	40	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep40	40	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep40	40	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep40	40	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep40	40	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep40	40	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep40	40	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep40	40	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep41	41	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep41	41	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep41	41	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep41	41	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep41	41	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep41	41	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep41	41	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep41	41	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep41	41	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep41	41	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep41	41	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep41	41	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep41	41	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep41	41	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep41	41	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep42	42	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep42	42	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep42	42	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep42	42	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep42	42	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep42	42	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep42	42	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep42	42	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep42	42	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep42	42	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep42	42	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep42	42	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep42	42	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep42	42	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep42	42	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep43	43	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep43	43	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep43	43	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep43	43	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep43	43	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep43	43	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep43	43	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep43	43	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep43	43	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep43	43	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep43	43	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep43	43	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep43	43	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep43	43	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep43	43	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep44	44	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep44	44	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep44	44	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep44	44	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep44	44	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep44	44	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep44	44	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep44	44	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep44	44	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep44	44	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep44	44	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep44	44	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep44	44	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep44	44	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep44	44	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep45	45	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep45	45	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep45	45	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep45	45	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep45	45	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep45	45	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep45	45	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep45	45	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep45	45	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep45	45	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep45	45	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep45	45	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep45	45	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep45	45	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep45	45	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep46	46	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep46	46	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep46	46	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep46	46	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep46	46	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep46	46	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep46	46	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep46	46	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep46	46	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep46	46	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep46	46	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep46	46	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep46	46	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep46	46	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep46	46	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep47	47	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep47	47	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep47	47	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep47	47	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep47	47	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep47	47	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep47	47	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep47	47	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep47	47	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep47	47	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep47	47	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep47	47	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep47	47	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep47	47	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep47	47	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep48	48	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep48	48	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep48	48	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep48	48	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep48	48	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep48	48	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep48	48	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep48	48	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep48	48	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep48	48	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep48	48	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep48	48	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep48	48	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep48	48	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep48	48	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep49	49	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep49	49	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep49	49	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep49	49	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep49	49	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep49	49	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep49	49	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep49	49	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep49	49	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep49	49	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep49	49	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep49	49	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep49	49	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep49	49	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep49	49	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep50	50	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep50	50	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep50	50	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep50	50	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep50	50	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep50	50	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep50	50	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep50	50	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep50	50	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep50	50	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep50	50	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep50	50	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep50	50	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep50	50	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep50	50	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep51	51	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep51	51	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep51	51	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep51	51	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep51	51	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep51	51	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep51	51	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep51	51	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep51	51	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep51	51	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep51	51	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep51	51	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep51	51	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep51	51	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep51	51	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep52	52	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep52	52	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep52	52	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep52	52	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep52	52	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep52	52	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep52	52	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep52	52	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep52	52	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep52	52	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep52	52	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep52	52	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep52	52	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep52	52	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep52	52	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep53	53	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep53	53	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep53	53	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep53	53	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep53	53	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep53	53	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep53	53	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep53	53	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep53	53	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep53	53	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep53	53	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep53	53	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep53	53	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep53	53	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep53	53	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep54	54	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep54	54	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep54	54	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep54	54	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep54	54	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep54	54	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep54	54	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep54	54	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep54	54	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep54	54	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep54	54	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep54	54	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep54	54	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep54	54	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep54	54	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep55	55	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep55	55	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep55	55	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep55	55	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep55	55	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep55	55	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep55	55	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep55	55	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep55	55	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep55	55	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep55	55	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep55	55	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep55	55	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep55	55	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep55	55	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep56	56	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep56	56	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep56	56	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep56	56	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep56	56	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep56	56	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep56	56	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep56	56	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep56	56	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep56	56	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep56	56	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep56	56	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep56	56	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep56	56	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep56	56	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep57	57	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep57	57	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep57	57	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep57	57	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep57	57	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep57	57	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep57	57	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep57	57	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep57	57	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep57	57	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep57	57	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep57	57	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep57	57	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep57	57	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep57	57	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep58	58	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep58	58	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep58	58	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep58	58	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep58	58	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep58	58	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep58	58	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep58	58	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep58	58	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep58	58	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep58	58	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep58	58	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep58	58	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep58	58	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep58	58	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep59	59	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep59	59	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep59	59	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep59	59	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep59	59	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep59	59	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep59	59	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep59	59	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep59	59	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep59	59	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep59	59	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep59	59	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep59	59	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep59	59	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep59	59	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0_rep60	60	0	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-01_rep60	60	1e-04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-1_rep60	60	0.001	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-11_rep60	60	0.0011	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	11000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-3_rep60	60	0.003	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	30000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_0-7_rep60	60	0.007	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	70000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1_rep60	60	0.01	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	100000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_1-8_rep60	60	0.018	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	180000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_2-5_rep60	60	0.025	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	250000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_4_rep60	60	0.04	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	400000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_5_rep60	60	0.05	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_10_rep60	60	0.1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_25_rep60	60	0.25	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2500000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_50_rep60	60	0.5	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
10M_mix_Bmap_CLBGA_100_rep60	60	1	10000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep1	1	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep1	1	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep1	1	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep1	1	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep1	1	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep1	1	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep1	1	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep1	1	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep1	1	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep1	1	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep1	1	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep1	1	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep1	1	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep1	1	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep1	1	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep2	2	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep2	2	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep2	2	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep2	2	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep2	2	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep2	2	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep2	2	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep2	2	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep2	2	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep2	2	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep2	2	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep2	2	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep2	2	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep2	2	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep2	2	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep3	3	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep3	3	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep3	3	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep3	3	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep3	3	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep3	3	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep3	3	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep3	3	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep3	3	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep3	3	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep3	3	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep3	3	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep3	3	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep3	3	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep3	3	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep4	4	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep4	4	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep4	4	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep4	4	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep4	4	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep4	4	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep4	4	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep4	4	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep4	4	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep4	4	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep4	4	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep4	4	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep4	4	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep4	4	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep4	4	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep5	5	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep5	5	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep5	5	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep5	5	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep5	5	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep5	5	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep5	5	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep5	5	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep5	5	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep5	5	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep5	5	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep5	5	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep5	5	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep5	5	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep5	5	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep6	6	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep6	6	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep6	6	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep6	6	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep6	6	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep6	6	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep6	6	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep6	6	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep6	6	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep6	6	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep6	6	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep6	6	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep6	6	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep6	6	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep6	6	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep7	7	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep7	7	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep7	7	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep7	7	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep7	7	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep7	7	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep7	7	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep7	7	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep7	7	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep7	7	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep7	7	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep7	7	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep7	7	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep7	7	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep7	7	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep8	8	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep8	8	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep8	8	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep8	8	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep8	8	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep8	8	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep8	8	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep8	8	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep8	8	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep8	8	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep8	8	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep8	8	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep8	8	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep8	8	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep8	8	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep9	9	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep9	9	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep9	9	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep9	9	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep9	9	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep9	9	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep9	9	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep9	9	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep9	9	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep9	9	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep9	9	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep9	9	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep9	9	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep9	9	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep9	9	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep10	10	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep10	10	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep10	10	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep10	10	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep10	10	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep10	10	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep10	10	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep10	10	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep10	10	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep10	10	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep10	10	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep10	10	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep10	10	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep10	10	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep10	10	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep11	11	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep11	11	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep11	11	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep11	11	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep11	11	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep11	11	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep11	11	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep11	11	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep11	11	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep11	11	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep11	11	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep11	11	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep11	11	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep11	11	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep11	11	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep12	12	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep12	12	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep12	12	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep12	12	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep12	12	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep12	12	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep12	12	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep12	12	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep12	12	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep12	12	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep12	12	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep12	12	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep12	12	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep12	12	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep12	12	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep13	13	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep13	13	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep13	13	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep13	13	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep13	13	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep13	13	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep13	13	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep13	13	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep13	13	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep13	13	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep13	13	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep13	13	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep13	13	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep13	13	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep13	13	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep14	14	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep14	14	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep14	14	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep14	14	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep14	14	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep14	14	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep14	14	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep14	14	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep14	14	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep14	14	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep14	14	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep14	14	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep14	14	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep14	14	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep14	14	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep15	15	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep15	15	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep15	15	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep15	15	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep15	15	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep15	15	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep15	15	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep15	15	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep15	15	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep15	15	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep15	15	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep15	15	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep15	15	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep15	15	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep15	15	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep16	16	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep16	16	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep16	16	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep16	16	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep16	16	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep16	16	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep16	16	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep16	16	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep16	16	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep16	16	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep16	16	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep16	16	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep16	16	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep16	16	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep16	16	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep17	17	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep17	17	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep17	17	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep17	17	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep17	17	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep17	17	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep17	17	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep17	17	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep17	17	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep17	17	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep17	17	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep17	17	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep17	17	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep17	17	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep17	17	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep18	18	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep18	18	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep18	18	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep18	18	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep18	18	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep18	18	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep18	18	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep18	18	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep18	18	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep18	18	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep18	18	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep18	18	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep18	18	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep18	18	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep18	18	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep19	19	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep19	19	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep19	19	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep19	19	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep19	19	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep19	19	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep19	19	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep19	19	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep19	19	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep19	19	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep19	19	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep19	19	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep19	19	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep19	19	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep19	19	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep20	20	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep20	20	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep20	20	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep20	20	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep20	20	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep20	20	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep20	20	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep20	20	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep20	20	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep20	20	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep20	20	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep20	20	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep20	20	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep20	20	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep20	20	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep21	21	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep21	21	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep21	21	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep21	21	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep21	21	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep21	21	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep21	21	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep21	21	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep21	21	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep21	21	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep21	21	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep21	21	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep21	21	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep21	21	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep21	21	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep22	22	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep22	22	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep22	22	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep22	22	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep22	22	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep22	22	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep22	22	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep22	22	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep22	22	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep22	22	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep22	22	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep22	22	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep22	22	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep22	22	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep22	22	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep23	23	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep23	23	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep23	23	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep23	23	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep23	23	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep23	23	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep23	23	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep23	23	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep23	23	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep23	23	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep23	23	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep23	23	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep23	23	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep23	23	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep23	23	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep24	24	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep24	24	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep24	24	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep24	24	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep24	24	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep24	24	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep24	24	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep24	24	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep24	24	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep24	24	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep24	24	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep24	24	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep24	24	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep24	24	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep24	24	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep25	25	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep25	25	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep25	25	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep25	25	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep25	25	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep25	25	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep25	25	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep25	25	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep25	25	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep25	25	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep25	25	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep25	25	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep25	25	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep25	25	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep25	25	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep26	26	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep26	26	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep26	26	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep26	26	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep26	26	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep26	26	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep26	26	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep26	26	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep26	26	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep26	26	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep26	26	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep26	26	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep26	26	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep26	26	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep26	26	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep27	27	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep27	27	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep27	27	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep27	27	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep27	27	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep27	27	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep27	27	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep27	27	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep27	27	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep27	27	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep27	27	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep27	27	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep27	27	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep27	27	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep27	27	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep28	28	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep28	28	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep28	28	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep28	28	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep28	28	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep28	28	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep28	28	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep28	28	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep28	28	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep28	28	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep28	28	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep28	28	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep28	28	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep28	28	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep28	28	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep29	29	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep29	29	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep29	29	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep29	29	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep29	29	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep29	29	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep29	29	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep29	29	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep29	29	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep29	29	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep29	29	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep29	29	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep29	29	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep29	29	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep29	29	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep30	30	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep30	30	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep30	30	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep30	30	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep30	30	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep30	30	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep30	30	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep30	30	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep30	30	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep30	30	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep30	30	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep30	30	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep30	30	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep30	30	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep30	30	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep31	31	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep31	31	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep31	31	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep31	31	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep31	31	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep31	31	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep31	31	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep31	31	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep31	31	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep31	31	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep31	31	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep31	31	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep31	31	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep31	31	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep31	31	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep32	32	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep32	32	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep32	32	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep32	32	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep32	32	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep32	32	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep32	32	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep32	32	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep32	32	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep32	32	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep32	32	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep32	32	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep32	32	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep32	32	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep32	32	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep33	33	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep33	33	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep33	33	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep33	33	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep33	33	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep33	33	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep33	33	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep33	33	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep33	33	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep33	33	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep33	33	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep33	33	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep33	33	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep33	33	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep33	33	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep34	34	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep34	34	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep34	34	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep34	34	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep34	34	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep34	34	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep34	34	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep34	34	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep34	34	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep34	34	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep34	34	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep34	34	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep34	34	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep34	34	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep34	34	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep35	35	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep35	35	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep35	35	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep35	35	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep35	35	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep35	35	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep35	35	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep35	35	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep35	35	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep35	35	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep35	35	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep35	35	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep35	35	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep35	35	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep35	35	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep36	36	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep36	36	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep36	36	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep36	36	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep36	36	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep36	36	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep36	36	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep36	36	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep36	36	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep36	36	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep36	36	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep36	36	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep36	36	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep36	36	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep36	36	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep37	37	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep37	37	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep37	37	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep37	37	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep37	37	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep37	37	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep37	37	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep37	37	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep37	37	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep37	37	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep37	37	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep37	37	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep37	37	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep37	37	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep37	37	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep38	38	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep38	38	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep38	38	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep38	38	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep38	38	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep38	38	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep38	38	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep38	38	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep38	38	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep38	38	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep38	38	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep38	38	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep38	38	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep38	38	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep38	38	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep39	39	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep39	39	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep39	39	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep39	39	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep39	39	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep39	39	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep39	39	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep39	39	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep39	39	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep39	39	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep39	39	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep39	39	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep39	39	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep39	39	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep39	39	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep40	40	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep40	40	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep40	40	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep40	40	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep40	40	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep40	40	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep40	40	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep40	40	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep40	40	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep40	40	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep40	40	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep40	40	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep40	40	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep40	40	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep40	40	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep41	41	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep41	41	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep41	41	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep41	41	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep41	41	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep41	41	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep41	41	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep41	41	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep41	41	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep41	41	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep41	41	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep41	41	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep41	41	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep41	41	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep41	41	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep42	42	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep42	42	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep42	42	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep42	42	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep42	42	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep42	42	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep42	42	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep42	42	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep42	42	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep42	42	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep42	42	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep42	42	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep42	42	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep42	42	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep42	42	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep43	43	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep43	43	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep43	43	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep43	43	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep43	43	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep43	43	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep43	43	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep43	43	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep43	43	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep43	43	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep43	43	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep43	43	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep43	43	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep43	43	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep43	43	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep44	44	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep44	44	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep44	44	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep44	44	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep44	44	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep44	44	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep44	44	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep44	44	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep44	44	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep44	44	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep44	44	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep44	44	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep44	44	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep44	44	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep44	44	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep45	45	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep45	45	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep45	45	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep45	45	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep45	45	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep45	45	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep45	45	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep45	45	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep45	45	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep45	45	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep45	45	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep45	45	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep45	45	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep45	45	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep45	45	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep46	46	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep46	46	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep46	46	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep46	46	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep46	46	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep46	46	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep46	46	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep46	46	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep46	46	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep46	46	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep46	46	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep46	46	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep46	46	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep46	46	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep46	46	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep47	47	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep47	47	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep47	47	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep47	47	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep47	47	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep47	47	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep47	47	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep47	47	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep47	47	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep47	47	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep47	47	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep47	47	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep47	47	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep47	47	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep47	47	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep48	48	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep48	48	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep48	48	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep48	48	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep48	48	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep48	48	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep48	48	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep48	48	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep48	48	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep48	48	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep48	48	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep48	48	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep48	48	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep48	48	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep48	48	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep49	49	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep49	49	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep49	49	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep49	49	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep49	49	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep49	49	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep49	49	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep49	49	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep49	49	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep49	49	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep49	49	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep49	49	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep49	49	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep49	49	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep49	49	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep50	50	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep50	50	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep50	50	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep50	50	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep50	50	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep50	50	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep50	50	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep50	50	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep50	50	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep50	50	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep50	50	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep50	50	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep50	50	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep50	50	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep50	50	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep51	51	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep51	51	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep51	51	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep51	51	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep51	51	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep51	51	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep51	51	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep51	51	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep51	51	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep51	51	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep51	51	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep51	51	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep51	51	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep51	51	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep51	51	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep52	52	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep52	52	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep52	52	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep52	52	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep52	52	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep52	52	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep52	52	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep52	52	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep52	52	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep52	52	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep52	52	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep52	52	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep52	52	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep52	52	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep52	52	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep53	53	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep53	53	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep53	53	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep53	53	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep53	53	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep53	53	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep53	53	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep53	53	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep53	53	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep53	53	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep53	53	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep53	53	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep53	53	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep53	53	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep53	53	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep54	54	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep54	54	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep54	54	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep54	54	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep54	54	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep54	54	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep54	54	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep54	54	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep54	54	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep54	54	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep54	54	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep54	54	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep54	54	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep54	54	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep54	54	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep55	55	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep55	55	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep55	55	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep55	55	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep55	55	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep55	55	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep55	55	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep55	55	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep55	55	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep55	55	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep55	55	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep55	55	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep55	55	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep55	55	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep55	55	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep56	56	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep56	56	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep56	56	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep56	56	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep56	56	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep56	56	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep56	56	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep56	56	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep56	56	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep56	56	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep56	56	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep56	56	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep56	56	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep56	56	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep56	56	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep57	57	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep57	57	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep57	57	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep57	57	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep57	57	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep57	57	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep57	57	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep57	57	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep57	57	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep57	57	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep57	57	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep57	57	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep57	57	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep57	57	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep57	57	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep58	58	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep58	58	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep58	58	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep58	58	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep58	58	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep58	58	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep58	58	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep58	58	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep58	58	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep58	58	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep58	58	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep58	58	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep58	58	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep58	58	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep58	58	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep59	59	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep59	59	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep59	59	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep59	59	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep59	59	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep59	59	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep59	59	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep59	59	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep59	59	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep59	59	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep59	59	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep59	59	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep59	59	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep59	59	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep59	59	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0_rep60	60	0	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-01_rep60	60	1e-04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-1_rep60	60	0.001	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-11_rep60	60	0.0011	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	16500		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-3_rep60	60	0.003	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	45000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_0-7_rep60	60	0.007	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	105000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1_rep60	60	0.01	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	150000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_1-8_rep60	60	0.018	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	270000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_2-5_rep60	60	0.025	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	375000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_4_rep60	60	0.04	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	600000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_5_rep60	60	0.05	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_10_rep60	60	0.1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_25_rep60	60	0.25	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	3750000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_50_rep60	60	0.5	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	7500000		NA	NA	NA	NA
15M_mix_Bmap_CLBGA_100_rep60	60	1	15000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	15000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep1	1	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep1	1	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep1	1	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep1	1	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep1	1	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep1	1	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep1	1	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep1	1	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep1	1	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep1	1	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep1	1	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep1	1	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep1	1	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep1	1	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep1	1	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep2	2	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep2	2	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep2	2	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep2	2	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep2	2	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep2	2	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep2	2	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep2	2	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep2	2	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep2	2	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep2	2	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep2	2	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep2	2	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep2	2	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep2	2	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep3	3	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep3	3	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep3	3	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep3	3	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep3	3	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep3	3	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep3	3	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep3	3	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep3	3	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep3	3	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep3	3	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep3	3	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep3	3	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep3	3	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep3	3	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep4	4	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep4	4	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep4	4	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep4	4	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep4	4	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep4	4	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep4	4	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep4	4	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep4	4	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep4	4	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep4	4	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep4	4	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep4	4	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep4	4	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep4	4	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep5	5	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep5	5	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep5	5	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep5	5	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep5	5	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep5	5	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep5	5	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep5	5	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep5	5	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep5	5	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep5	5	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep5	5	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep5	5	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep5	5	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep5	5	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep6	6	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep6	6	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep6	6	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep6	6	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep6	6	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep6	6	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep6	6	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep6	6	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep6	6	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep6	6	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep6	6	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep6	6	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep6	6	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep6	6	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep6	6	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep7	7	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep7	7	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep7	7	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep7	7	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep7	7	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep7	7	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep7	7	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep7	7	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep7	7	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep7	7	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep7	7	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep7	7	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep7	7	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep7	7	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep7	7	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep8	8	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep8	8	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep8	8	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep8	8	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep8	8	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep8	8	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep8	8	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep8	8	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep8	8	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep8	8	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep8	8	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep8	8	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep8	8	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep8	8	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep8	8	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep9	9	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep9	9	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep9	9	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep9	9	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep9	9	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep9	9	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep9	9	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep9	9	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep9	9	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep9	9	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep9	9	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep9	9	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep9	9	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep9	9	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep9	9	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep10	10	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep10	10	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep10	10	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep10	10	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep10	10	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep10	10	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep10	10	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep10	10	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep10	10	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep10	10	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep10	10	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep10	10	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep10	10	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep10	10	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep10	10	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep11	11	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep11	11	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep11	11	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep11	11	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep11	11	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep11	11	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep11	11	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep11	11	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep11	11	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep11	11	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep11	11	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep11	11	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep11	11	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep11	11	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep11	11	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep12	12	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep12	12	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep12	12	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep12	12	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep12	12	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep12	12	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep12	12	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep12	12	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep12	12	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep12	12	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep12	12	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep12	12	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep12	12	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep12	12	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep12	12	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep13	13	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep13	13	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep13	13	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep13	13	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep13	13	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep13	13	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep13	13	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep13	13	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep13	13	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep13	13	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep13	13	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep13	13	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep13	13	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep13	13	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep13	13	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep14	14	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep14	14	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep14	14	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep14	14	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep14	14	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep14	14	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep14	14	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep14	14	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep14	14	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep14	14	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep14	14	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep14	14	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep14	14	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep14	14	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep14	14	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep15	15	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep15	15	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep15	15	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep15	15	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep15	15	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep15	15	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep15	15	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep15	15	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep15	15	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep15	15	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep15	15	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep15	15	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep15	15	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep15	15	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep15	15	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep16	16	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep16	16	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep16	16	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep16	16	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep16	16	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep16	16	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep16	16	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep16	16	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep16	16	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep16	16	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep16	16	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep16	16	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep16	16	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep16	16	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep16	16	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep17	17	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep17	17	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep17	17	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep17	17	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep17	17	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep17	17	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep17	17	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep17	17	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep17	17	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep17	17	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep17	17	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep17	17	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep17	17	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep17	17	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep17	17	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep18	18	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep18	18	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep18	18	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep18	18	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep18	18	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep18	18	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep18	18	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep18	18	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep18	18	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep18	18	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep18	18	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep18	18	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep18	18	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep18	18	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep18	18	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep19	19	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep19	19	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep19	19	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep19	19	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep19	19	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep19	19	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep19	19	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep19	19	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep19	19	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep19	19	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep19	19	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep19	19	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep19	19	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep19	19	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep19	19	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep20	20	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep20	20	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep20	20	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep20	20	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep20	20	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep20	20	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep20	20	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep20	20	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep20	20	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep20	20	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep20	20	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep20	20	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep20	20	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep20	20	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep20	20	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep21	21	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep21	21	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep21	21	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep21	21	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep21	21	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep21	21	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep21	21	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep21	21	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep21	21	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep21	21	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep21	21	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep21	21	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep21	21	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep21	21	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep21	21	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep22	22	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep22	22	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep22	22	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep22	22	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep22	22	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep22	22	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep22	22	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep22	22	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep22	22	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep22	22	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep22	22	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep22	22	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep22	22	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep22	22	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep22	22	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep23	23	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep23	23	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep23	23	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep23	23	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep23	23	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep23	23	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep23	23	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep23	23	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep23	23	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep23	23	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep23	23	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep23	23	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep23	23	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep23	23	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep23	23	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep24	24	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep24	24	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep24	24	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep24	24	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep24	24	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep24	24	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep24	24	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep24	24	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep24	24	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep24	24	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep24	24	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep24	24	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep24	24	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep24	24	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep24	24	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep25	25	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep25	25	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep25	25	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep25	25	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep25	25	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep25	25	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep25	25	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep25	25	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep25	25	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep25	25	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep25	25	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep25	25	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep25	25	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep25	25	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep25	25	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep26	26	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep26	26	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep26	26	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep26	26	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep26	26	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep26	26	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep26	26	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep26	26	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep26	26	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep26	26	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep26	26	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep26	26	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep26	26	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep26	26	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep26	26	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep27	27	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep27	27	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep27	27	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep27	27	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep27	27	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep27	27	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep27	27	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep27	27	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep27	27	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep27	27	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep27	27	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep27	27	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep27	27	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep27	27	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep27	27	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep28	28	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep28	28	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep28	28	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep28	28	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep28	28	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep28	28	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep28	28	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep28	28	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep28	28	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep28	28	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep28	28	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep28	28	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep28	28	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep28	28	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep28	28	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep29	29	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep29	29	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep29	29	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep29	29	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep29	29	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep29	29	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep29	29	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep29	29	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep29	29	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep29	29	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep29	29	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep29	29	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep29	29	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep29	29	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep29	29	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep30	30	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep30	30	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep30	30	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep30	30	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep30	30	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep30	30	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep30	30	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep30	30	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep30	30	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep30	30	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep30	30	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep30	30	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep30	30	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep30	30	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep30	30	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep31	31	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep31	31	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep31	31	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep31	31	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep31	31	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep31	31	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep31	31	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep31	31	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep31	31	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep31	31	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep31	31	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep31	31	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep31	31	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep31	31	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep31	31	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep32	32	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep32	32	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep32	32	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep32	32	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep32	32	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep32	32	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep32	32	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep32	32	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep32	32	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep32	32	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep32	32	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep32	32	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep32	32	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep32	32	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep32	32	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep33	33	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep33	33	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep33	33	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep33	33	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep33	33	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep33	33	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep33	33	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep33	33	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep33	33	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep33	33	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep33	33	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep33	33	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep33	33	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep33	33	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep33	33	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep34	34	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep34	34	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep34	34	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep34	34	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep34	34	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep34	34	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep34	34	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep34	34	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep34	34	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep34	34	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep34	34	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep34	34	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep34	34	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep34	34	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep34	34	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep35	35	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep35	35	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep35	35	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep35	35	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep35	35	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep35	35	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep35	35	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep35	35	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep35	35	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep35	35	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep35	35	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep35	35	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep35	35	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep35	35	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep35	35	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep36	36	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep36	36	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep36	36	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep36	36	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep36	36	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep36	36	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep36	36	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep36	36	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep36	36	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep36	36	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep36	36	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep36	36	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep36	36	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep36	36	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep36	36	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep37	37	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep37	37	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep37	37	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep37	37	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep37	37	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep37	37	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep37	37	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep37	37	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep37	37	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep37	37	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep37	37	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep37	37	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep37	37	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep37	37	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep37	37	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep38	38	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep38	38	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep38	38	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep38	38	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep38	38	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep38	38	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep38	38	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep38	38	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep38	38	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep38	38	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep38	38	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep38	38	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep38	38	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep38	38	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep38	38	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep39	39	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep39	39	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep39	39	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep39	39	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep39	39	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep39	39	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep39	39	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep39	39	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep39	39	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep39	39	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep39	39	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep39	39	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep39	39	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep39	39	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep39	39	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep40	40	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep40	40	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep40	40	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep40	40	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep40	40	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep40	40	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep40	40	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep40	40	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep40	40	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep40	40	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep40	40	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep40	40	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep40	40	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep40	40	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep40	40	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep41	41	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep41	41	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep41	41	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep41	41	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep41	41	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep41	41	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep41	41	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep41	41	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep41	41	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep41	41	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep41	41	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep41	41	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep41	41	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep41	41	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep41	41	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep42	42	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep42	42	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep42	42	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep42	42	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep42	42	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep42	42	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep42	42	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep42	42	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep42	42	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep42	42	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep42	42	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep42	42	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep42	42	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep42	42	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep42	42	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep43	43	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep43	43	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep43	43	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep43	43	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep43	43	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep43	43	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep43	43	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep43	43	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep43	43	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep43	43	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep43	43	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep43	43	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep43	43	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep43	43	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep43	43	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep44	44	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep44	44	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep44	44	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep44	44	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep44	44	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep44	44	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep44	44	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep44	44	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep44	44	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep44	44	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep44	44	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep44	44	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep44	44	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep44	44	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep44	44	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep45	45	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep45	45	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep45	45	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep45	45	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep45	45	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep45	45	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep45	45	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep45	45	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep45	45	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep45	45	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep45	45	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep45	45	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep45	45	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep45	45	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep45	45	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep46	46	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep46	46	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep46	46	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep46	46	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep46	46	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep46	46	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep46	46	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep46	46	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep46	46	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep46	46	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep46	46	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep46	46	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep46	46	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep46	46	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep46	46	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep47	47	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep47	47	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep47	47	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep47	47	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep47	47	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep47	47	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep47	47	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep47	47	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep47	47	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep47	47	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep47	47	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep47	47	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep47	47	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep47	47	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep47	47	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep48	48	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep48	48	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep48	48	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep48	48	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep48	48	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep48	48	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep48	48	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep48	48	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep48	48	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep48	48	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep48	48	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep48	48	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep48	48	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep48	48	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep48	48	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep49	49	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep49	49	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep49	49	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep49	49	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep49	49	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep49	49	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep49	49	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep49	49	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep49	49	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep49	49	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep49	49	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep49	49	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep49	49	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep49	49	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep49	49	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep50	50	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep50	50	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep50	50	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep50	50	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep50	50	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep50	50	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep50	50	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep50	50	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep50	50	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep50	50	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep50	50	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep50	50	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep50	50	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep50	50	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep50	50	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep51	51	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep51	51	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep51	51	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep51	51	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep51	51	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep51	51	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep51	51	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep51	51	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep51	51	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep51	51	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep51	51	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep51	51	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep51	51	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep51	51	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep51	51	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep52	52	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep52	52	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep52	52	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep52	52	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep52	52	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep52	52	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep52	52	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep52	52	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep52	52	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep52	52	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep52	52	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep52	52	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep52	52	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep52	52	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep52	52	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep53	53	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep53	53	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep53	53	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep53	53	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep53	53	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep53	53	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep53	53	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep53	53	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep53	53	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep53	53	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep53	53	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep53	53	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep53	53	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep53	53	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep53	53	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep54	54	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep54	54	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep54	54	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep54	54	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep54	54	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep54	54	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep54	54	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep54	54	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep54	54	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep54	54	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep54	54	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep54	54	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep54	54	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep54	54	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep54	54	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep55	55	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep55	55	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep55	55	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep55	55	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep55	55	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep55	55	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep55	55	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep55	55	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep55	55	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep55	55	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep55	55	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep55	55	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep55	55	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep55	55	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep55	55	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep56	56	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep56	56	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep56	56	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep56	56	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep56	56	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep56	56	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep56	56	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep56	56	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep56	56	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep56	56	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep56	56	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep56	56	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep56	56	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep56	56	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep56	56	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep57	57	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep57	57	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep57	57	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep57	57	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep57	57	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep57	57	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep57	57	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep57	57	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep57	57	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep57	57	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep57	57	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep57	57	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep57	57	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep57	57	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep57	57	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep58	58	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep58	58	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep58	58	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep58	58	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep58	58	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep58	58	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep58	58	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep58	58	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep58	58	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep58	58	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep58	58	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep58	58	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep58	58	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep58	58	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep58	58	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep59	59	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep59	59	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep59	59	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep59	59	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep59	59	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep59	59	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep59	59	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep59	59	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep59	59	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep59	59	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep59	59	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep59	59	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep59	59	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep59	59	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep59	59	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0_rep60	60	0	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	0		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-01_rep60	60	1e-04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-1_rep60	60	0.001	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-11_rep60	60	0.0011	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	22000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-3_rep60	60	0.003	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	60000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_0-7_rep60	60	0.007	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	140000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1_rep60	60	0.01	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	200000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_1-8_rep60	60	0.018	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	360000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_2-5_rep60	60	0.025	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	500000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_4_rep60	60	0.04	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	800000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_5_rep60	60	0.05	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	1000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_10_rep60	60	0.1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	2000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_25_rep60	60	0.25	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	5000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_50_rep60	60	0.5	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	10000000		NA	NA	NA	NA
20M_mix_Bmap_CLBGA_100_rep60	60	1	20000000	in silico samples made with the 0% and 100% tumour in vitro mixtures (CLBGA cell line & cfDNA pool)	Before mapping	20000000		NA	NA	NA	NA
DNA100355_S2	NA	1	26147154	mixing of CLBGA cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	10ng	100	1	1.050228311
DNA100356_S3	NA	0.5	25594720	mixing of CLBGA cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	10ng	50	0.5	0.647186147
DNA100357_S4	NA	0.25	24538492	mixing of CLBGA cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	10ng	26.45	0.2645	0.342624065
DNA100358_S5	NA	0.1	29239327	mixing of CLBGA cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	10ng	11.7	0.117	0.15547025
DNA100359_S6	NA	0.04	31648513	mixing of CLBGA cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	10ng	4.82	0.0482	0.084548105
DNA100360_S7	NA	0.018	29694143	mixing of CLBGA cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	10ng	1.92	0.0192	0.028149191
DNA100361_S8	NA	0.007	23938280	mixing of CLBGA cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	10ng	0.76	0.0076	0.012084592
DNA100362_S9	NA	0.003	21437483	mixing of CLBGA cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	10ng	0.3	0.003	0.002828854
DNA100363_S10	NA	0.0011	27846257	mixing of CLBGA cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	10ng	0.12	0.0012	0.006010518
DNA100364_S11	NA	0	30032335	mixing of CLBGA cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	10ng	0	0	0
DNA100365_S12	NA	1	21931799	mixing of CLBGA cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	100	1	0.914454277
DNA100366_S13	NA	0.5	26277862	mixing of CLBGA cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	50	0.5	0.687707641
DNA100367_S14	NA	0.25	30424556	mixing of CLBGA cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	26.45	0.2645	0.376712329
DNA100368_S15	NA	0.1	23780393	mixing of CLBGA cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	11.7	0.117	0.137457045
DNA100369_S16	NA	0.04	24758590	mixing of CLBGA cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	4.82	0.0482	0.0642978
DNA100370_S17	NA	0.018	27782104	mixing of CLBGA cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	1.92	0.0192	0.014466546
DNA100371_S18	NA	0.007	28626067	mixing of CLBGA cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	0.76	0.0076	0.005813953
DNA100372_S19	NA	0.003	24089633	mixing of CLBGA cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	0.3	0.003	0.003236246
DNA100373_S20	NA	0.0011	27745110	mixing of CLBGA cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	0.12	0.0012	0.007285974
DNA100374_S21	NA	0	32850068	mixing of CLBGA cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	0	0	0
DNA100375_S22	NA	1	27374060	mixing of CLBGA cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	1.5ng	100	1	0.944281525
DNA100376_S23	NA	0.5	28028020	mixing of CLBGA cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	1.5ng	50	0.5	0.582524272
DNA100377_S24	NA	0.25	26490022	mixing of CLBGA cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	1.5ng	26.45	0.2645	0.307086614
DNA100378_S25	NA	0.1	25507658	mixing of CLBGA cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	1.5ng	11.7	0.117	0.144486692
DNA100379_S26	NA	0.04	26310292	mixing of CLBGA cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	1.5ng	4.82	0.0482	0.05904059
DNA100380_S27	NA	0.018	24797257	mixing of CLBGA cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	1.5ng	1.92	0.0192	0.048
DNA100381_S28	NA	0.007	24402659	mixing of CLBGA cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	1.5ng	0.76	0.0076	0.023715415
DNA100382_S29	NA	0.003	21103570	mixing of CLBGA cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	1.5ng	0.3	0.003	0
DNA100383_S30	NA	0.0011	27719441	mixing of CLBGA cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	1.5ng	0.12	0.0012	0
DNA100384_S31	NA	0	21861415	mixing of CLBGA cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	1.5ng	0	0	0
DNA082414_S22	NA	0.5	15550300	mixing of SHEP cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	50	0.5	0.634092518
DNA082415_S23	NA	0.25	28140076	mixing of SHEP cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	23.8474259	0.238474259	0.404963575
DNA082416_S24	NA	0.1	13364649	mixing of SHEP cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	10.2051266	0.102051266	0.21067934
DNA082417_S25	NA	0.04	29838833	mixing of SHEP cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	4.145146	0.04145146	0.111434452
DNA082418_S26	NA	0.015	12635995	mixing of SHEP cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	1.6465111	0.016465111	0.058940934
DNA082419_S27	NA	0.006	28391230	mixing of SHEP cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	0.6481172	0.006481172	0.031175581
DNA082420_S28	NA	0.002	14079030	mixing of SHEP cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	0.2542025	0.002542025	0.016489675
DNA082421_S29	NA	0	28545906	mixing of SHEP cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	0	0	0
DNA082429_S10	NA	1	33196353	mixing of SHEP cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	100	1	1
DNA053894_S2	NA	0.5	23604375	mixing of SKNBE2C cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	50	0.5	0.496527778
DNA053895_S3	NA	0.2539	22100158	mixing of SKNBE2C cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	24.15	0.2415	0.234913793
DNA053896_S4	NA	0.1054	23000783	mixing of SKNBE2C cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	9.77	0.0977	0.083710407
DNA053897_S5	NA	0.0396	25553120	mixing of SKNBE2C cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	3.63	0.0363	0.039307715
DNA053898_S6	NA	0.0142	11151867	mixing of SKNBE2C cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	1.3	0.013	0.025890797
DNA053899_S7	NA	0.0051	22369379	mixing of SKNBE2C cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	0.46	0.0046	0.00700264
DNA053900_S8	NA	0.0018	26633349	mixing of SKNBE2C cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	0.16	0.0016	0
DNA053901_S9	NA	0	16011816	mixing of SKNBE2C cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	0	0	0
DNA054053_S10	NA	1	29877560	mixing of SKNBE2C cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	100	1	1
DNA082422_S3	NA	0.5	28877317	mixing of SHSY5Y cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	50	0.5	0.88123258
DNA082423_S4	NA	0.25	28639427	mixing of SHSY5Y cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	25.3177291	0.253177291	0.224413402
DNA082424_S5	NA	0.1	27446529	mixing of SHSY5Y cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	10.8988632	0.108988632	0.118730389
DNA082425_S6	NA	0.04	35725833	mixing of SHSY5Y cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	4.3141528	0.043141528	0.064164744
DNA082426_S7	NA	0.015	25685943	mixing of SHSY5Y cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	1.6471501	0.016471501	0.034676164
DNA082427_S8	NA	0.006	24010502	mixing of SHSY5Y cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	0.6199818	0.006199818	0.018739829
DNA082428_S9	NA	0.002	24743511	mixing of SHSY5Y cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	0.2320936	0.002320936	0.010127452
DNA082430_S11	NA	1	28037371	mixing of SHSY5Y cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	100	1	1
DNA082421_S29	NA	0	28545906	mixing of SHSY5Y cell line DNA & cfDNA pool of healthy volunteers	NA	NA	in vitro	3.5ng	0	0	0
